ApoE genotypes in Australia: Roles in early and late onset Alzheimer’s disease and down’s syndrome

Ralph N. Martins*, Roger Clarnette, Christopher Fisher, Gerald A. Broe, William S. Brooks, Philip Montgomery, Samuel E. Gandy

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

97 Citations (Scopus)


WE studied the apoE genotypes of 279 Australians in order to determine what relationships might exist in this group between apoE genotype and dementia associated with either early- or late-onset sporadic Alzheimer’s disease (AD) or with Down’s syndrome (DS). ApoE ε4 allele frequency was increased in Australians with either early-onset sporadic AD (p < 0.002) or late-onset sporadic AD (p < 0.0001) and apoE ε2 allele frequency was decreased in the late-onset sporadic AD group (p < 0.01). The apoE genotype distribution among patients with DS was not different from that of the control group. One individual with DS and an apoE ε4/ε4 genotype developed dementia at the earliest age of dementing DS patients, consistent with a role for apoE ε4 in determining age of onset of dementia in AD and DS. Another DS patient with an apoE ε2/ε3 genotype developed dementia within an age range similar to that of four demented DS patients with an apoE ε3/ε3 genotype, an observation which would appear inconsistent with the proposed protective effect of apoE ε2 to delay onset of dementia in DS. These results extend the evidence that the apoE genotype, particularly apoE ε4, modulates dementia in early- and late-onset sporadic AD and DS. The protective role of apoE ε2 in DS, however, may vary among different populations or ethnic groups.

Original languageEnglish
Pages (from-to)1513-1516
Number of pages4
Issue number11
Publication statusPublished - 1995
Externally publishedYes


  • Alzheimer’s disease
  • Apolipoprotein E
  • Down’s syndrome
  • Early-onset
  • Late-onset
  • Sporadic
  • β-Amyloid


Dive into the research topics of 'ApoE genotypes in Australia: Roles in early and late onset Alzheimer’s disease and down’s syndrome'. Together they form a unique fingerprint.

Cite this